Clinical prognostic methods: Trends and developments Editor’s Note by unknown
Journal of Biomedical Informatics 48 (2014) 1–4Contents lists available at ScienceDirect
Journal of Biomedical Informatics
journal homepage: www.elsevier .com/locate /y jb inClinical prognostic methods: Trends and developmentshttp://dx.doi.org/10.1016/j.jbi.2014.02.016
1532-0464/ 2014 Elsevier Inc. All rights reserved.Editor’s Note
The following guest editorial provides an overview and analysis of a new ‘‘virtual issue’’ of JBI that appears on the journal’s web site (http://
www.journals.elsevier.com/journal-of-biomedical-informatics/virtual-special-issues/clinical-prognostic-methods/). We have recently intro-
duced the notion of such virtual issues, which gather together and analyze sets of articles that were previously published in JBI. Our ﬁrst virtual
issue, dealing with computer-interpretable clinical guidelines, was prepared by Dr. Mor Peleg and has been well received (see http://
www.journals.elsevier.com/journal-of-biomedical-informatics/virtual-special-issues/computer-interpretable-clinical-guidelines/). In coming
months you will ﬁnd additional such virtual issues prepared and published on the web site.
Edward H. Shortliffe, MD, Ph.D.
Editor-in-ChiefGuest-EditorialIntroduction
Prediction of health related patient outcomes is increasingly rec-
ognized as an essential activity in clinical decision making, clinical
research, and healthcare quality assessment [1–8]. In clinical deci-
sion making, treatment is typically initiated if a poor outcome is pre-
dicted when leaving a condition untreated. For instance, European
guidelines on cardiovascular risk management [9] recommend that
the decision of initiating preventive treatment is based on the SCORE
function [10], which estimates the ten-year risk of fatal cardiovascu-
lar disease for a given individual. Similarly, prognostic consider-
ations are usually paramount when choosing among competing
therapies. In clinical research, selection of patients for clinical trials
is often based on illness severity at baseline, expressed as the risk
of a poor outcome, which is derived by a prognostic model. In
healthcare quality assessment, fair comparison between care provid-
ers requires that observed outcomes (such as mortality) are com-
pared with outcomes that one would expect when considering the
mix of patients who were treated (case-mix adjustment). For exam-
ple, several countries use hospital standardized mortality ratios
(HSMRs) to detect variations in quality of care. The HSMR is a ratio
of observed to expected deaths, where the latter are computed with
prognostic models which adjust for several patient factors obtained
from routinely collected hospital administrative databases [11,12].
Although most prognostic research is carried out with statistical
regression methods (e.g., linear, logistic and Cox regression analysis)
[13], computer scientists have contributed to the ﬁeld by developing,
adapting and applying methods from machine learning and data
mining to clinical prediction problems [14–17]. This virtual issue
collects all papers on clinical prognostic methods pertaining to
patient outcomes that were published in the Journal of BiomedicalInformatics (JBI) between January 1, 2010 and June 30, 2013. This
editorial reviews the included papers, draws general conclusions
on prognostic research that is published in JBI, and identiﬁes oppor-
tunities for future research on the topic.Methods
We hand-searched all issues of JBI published between January 1,
2010 and June 30, 2013, using titles and abstracts to identify original
research on clinical prognostic methods of patient outcomes. When
this was not sufﬁcient to decide upon inclusion, the full text was
consulted. Editorials, letters, book reviews and methodological
reviews were excluded. Non-clinical research (e.g., papers in transla-
tional bioinformatics) were excluded. The resulting studies were
compared by assessing the prediction task, model type, data source,
learning algorithm, and approach to evaluate the method.
Results
Overall, eleven papers were selected for this virtual issue (listed
after references as citations [29–39]). Most of them focus on the
extension or adaptation of inductive methods for predictive chal-
lenges in the biomedical domain, such as integrating information
from PubMed with EHR data [29] and identifying predictive combi-
nations of monitor alarms in critical care [30]. The clinical areas that
are addressed in the papers include preventive medicine, survival in
acute and critical care, and prognosis after cancer and
transplantations.
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There are two types of task usually addressed in prognostic
model research. The ﬁrst task is risk prediction, which is concerned
with estimating the probability that a certain (adverse) event will
occur within a given time frame, based on binary patient outcomes.
In the biomedical scientiﬁc literature, logistic regression models [18]
are the predominant choice for this type of problem. In this virtual
issue, eight papers address risk prediction [29–36]. For instance, Vis-
weswaran et al. [33] study the efﬁcacy of patient-speciﬁc Bayesian
networks for predicting death within 90 days in patients that were
hospitalized for community acquired pneumonia.
The second task in prognostic model research is time-to-event
prediction, which is concerned with estimating the amount of time
that will pass until a predeﬁned event will occur, if it will occur at
all. Time-to-event prediction is possible when recorded binary
patient outcomes are accompanied by time (or date) of occurrence,
which is frequently the case in medical datasets. In general, this type
of prediction yields more ﬁne-grained prognostic information than
plain risk prediction because it distinguishes between early and late
occurrences of adverse outcomes. The analysis of time-to-event data
is also more complicated, because patients included in the dataset
may not (yet) have experienced the outcome and thus have no event
time recorded. These observations are said to be censored. In statis-
tics and epidemiology, Cox proportional hazards (CPH) regression
analysis [19], a generalization of logistic regression analysis, is the
method of choice for analyzing time-to-event data.
In this virtual issue, time-to-event prediction is addressed by two
papers [37,38]. The paper by Choi et al. [37] investigates a new
approach to variable selection in CPH regression models, using a
wrapper method that evaluates candidate models with cross-valida-
tion. Using simulated datasets and two clinical case studies they
demonstrate that the approach compares favorably with existing
variable selection methods such as stepwise selection and penalized
regression. The work by Stajduhar and Dalbelo-Bašic´ [38] focuses on
time-to-event prediction using Bayesian networks [20]. It combines
the method of Zupan et al. [15], which assigns distributions of out-
comes to censored observations, with two existing algorithms for
Bayesian network learning. From the experimental evaluation of
their method, the authors conclude that this approach is suitable
for datasets with intermediate censoring (40–60%), though only for
estimating the parameters of the network and not for assessing its
structure. In the case of more heavy censoring, CPH regression exhib-
its superior performance.
Model types
The choice of model type attracts much discussion in machine
learning. While statistical regression methods rely on polynomial
functions to express the relationship between predictors and out-
come in a prediction model, researchers in machine learning have
proposed sets, trees, graphs and many other symbolic-based repre-
sentations. These representations are often more expressive than
the polynomial functions used in regression models, and thus sup-
port descriptions of more sophisticated aspects of the prognostic
relationship such as nonlinear functions and interactions between
predictors. However, expression is a double-edged sword. Increased
freedom of expression implies that the search space of possible mod-
els is larger, and the selected model may reﬂect characteristics of the
data set that was used to derive it, instead of characteristics of the
population from which the data were sampled – a phenomenon
known as ‘‘overﬁtting’’. So, reducing the bias from a limited search
space increases the variability of the resulting models.
For example, after the initial euphoria over artiﬁcial neural net-
works (ANNs) in the 1990s, various studies were heavily criticized
for uncritical use of ANNs such as the ﬁtting of implausible riskfunctions [21]. The expressiveness of ANN models turned out to be
a potential disadvantage which had to be carefully addressed while
they were developed. Artiﬁcial neural networks are used in one
study included in this virtual issue. Trtica-Majnaric et al. [34] com-
pare three different types of ANN (multilayer perception, radial basis
network, and probabilistic neural network) and logistic regression
for the prediction of inﬂuenza vaccination outcomes. Accurate pre-
diction of vaccination efﬁcacy would open the door to individualized
vaccination schemes and ultimately, better control of inﬂuenza epi-
demics. The authors found that the multilayer perceptron outper-
formed the other ANN models and the logistic regression model. In
this study, overﬁtting the networks was avoided by strongly reduc-
ing the number of predictors beforehand and by using a split-sample
process during model development which alternatively trained and
tested the network using a separate test sample until the perfor-
mance of the network on the test sample no longer improved.
One model type that has gained considerable popularity since it
was ﬁrst described in the 1980s is the Bayesian network [20]. It
has become a common tool to model biomedical knowledge and
continues to be an active area of research. Three papers in this vir-
tual issue address the use of Bayesian networks. Visweswaran
et al. [33] investigate the use of patient-speciﬁc Bayesian networks
for outcome prediction. Essentially, this yields a more expressive
modeling language and hence a larger search space. The authors
use Bayesian model averaging to ‘‘smooth’’ the increased variation
in resulting models. From the experimental evaluation, they con-
clude that their approach is particularly valuable when the size of
the training dataset is small. The two other papers describe exten-
sions to Bayesian networks for speciﬁc types of clinical prediction
problems. Peelen et al. [31] extended dynamic Bayesian networks,
which are speciﬁcally suited for modeling repeated clinical observa-
tions over time, with hierarchical state variables. They use their
model to predict survival and length of stay in intensive care unit
(ICU) patients, based on daily organ failure measurements. The work
by Stajduhar and Dalbelo-Bašic´ [38], previously mentioned, extends
the conventional Bayesian network framework with methods for
time-to-event prediction.
Data sources
Traditionally, methods from machine learning and statistics have
assumed that the data source from which a model is built takes the
form of a single, ﬂat table in which each row represents an observa-
tion on one patient. In practice the data may take a different form,
for instance because patients were observed repeatedly over time
(temporal data). Information may also be scattered over different
data sets addressing the same problem, and even over different types
of information sources.
In this virtual issue, three studies [31,32,39] address prediction
from temporal data. Similar to Peelen et al. [31], Toma and col-
leagues [32] use data on organ failure in ICU patients, collected each
day during their stay at the ICU. Their models are built in two steps.
First, they identify frequently occurring patterns of organ failure
over time using an Apriori-like algorithm [22]. Then they use these
patterns to predict mortality risk using logistic regression models.
The paper by Li and colleagues [39] also uses temporal patient data,
but in this case the data are derived from multiple, cross-sectional
datasets concerning different patients in order to build a hidden
Markov model that explicitly describes the dynamics of disease.
Because the constructed disease trajectories in the temporal dataset
are inherently uncertain, they use bootstrapping to sample from the
underlying distribution of all possible trajectories when the model is
constructed.
A more radical approach to information fusion is taken in the
work by Tatari and colleagues [36] and the work by Zhao and Weng
[29]. The former present a risk assessment method that integrates
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‘‘hard’’ information from data, using the framework of fuzzy proba-
bility theory. Zhao and Weng combine information from PubMed
with data extracted from electronic health records to build a simple
Bayesian network (essentially a naive Bayes model) from risk predic-
tion. Their experimental results show that these models perform
much better than models that neglect the information from PubMed.
Evaluation
A prognostic model will not be trusted by its users unless it has
been shown to predict patient outcomes with some success. Validat-
ing a prognostic model means establishing that it performs satisfac-
torily for patients other than those whose data were used to derive
the model [23], and is essential for its credibility. Generally speaking
there are two categories of performance that are typically addressed
in prognostic model validation. First, a model should be able to dis-
tinguish groups of patients that have different outcomes. This is
called discrimination. For instance, the model should be able to dis-
tinguish survivors from nonsurvivors by systematically assigning
higher death risks to the latter than to the former. Second, the prob-
abilities that are estimated by a model should be faithful, i.e. close to
the real probabilities. This is called calibration. It strongly depends
on the intended application of the prognostic model which category
of performance is most important. Consequently, there exist mea-
sures that focus entirely on one category of performance, such as
the area under the ROC curve, which only assesses discrimination.
There are also performance measures that include aspects of both
categories. For example, the Brier score, which is the mean squared
error of the individual predictions, gauges aspects of discrimination
as well as calibration.
Researchers have distinguished three different validation
schemes, pertaining to increasingly stronger forms of generalizabil-
ity: internal validation, temporal validation, and external validation
[23]. Internal validation is typically performed by splitting the data-
set into two parts, or by cross-validation. It assesses the performance
of a model in the sample from which it was derived but avoids opti-
mistic bias by separating the data that are used for deriving the
model and the data used for assessing its predictive performance.
In this virtual issue, examples of internal validation are found in
the papers by Peelen et al. [31], Tatari et al. [36], and Choi et al. [37].
Temporal validation evaluates the performance of a model on
subsequent patients from the center(s) where the derivation dataset
was obtained, whereas external validation evaluates performance on
patients from other centers. In this virtual issue, Minne et al. [35]
temporally validate a decision tree model for predicting mortality
outcomes in elderly ICU patients. Generally speaking, in temporal
validation there will be many similarities between patients and
the clinical environment during the period for which the model
was developed and the period in which it is validated. Yet, over time
one will increasingly observe (small) changes in the datasets, due to
gradual changes in patient characteristics and/or medical treatment,
which may pose problems for the ‘‘shelf life’’ of a model. Using meth-
ods from the ﬁeld of Statistical Process Control [24], Minne and col-
leagues show that the mean squared error (the Brier score) of risks
predicted by a decision tree can quickly deteriorate over time even
though its discriminative ability remains stable.
In methodological research it is important to show that a newly
developed method has added value over existing methods. In prog-
nostic research, this means that one has to compare the performance
of the newmethod to the performance of existing methods on one or
more datasets. For instance, Stajduhar and Dalbelo-Bašic´ [38] per-
form such a comparison of their method with CPH regression on a
dataset of breast cancer patients. In such investigations, the statisti-
cal comparison of measured performance is a complicated issuebecause there are multiple sources of correlation which may bias
the results if not properly dealt with [25,26]. Both Stajduhar and
Dalbelo-Bašic´ [38] and Visweswaran et al. [33], in similar experi-
ments, use the Wilcoxon paired-samples signed-rank test which
was recommended by Demšar for this purpose [27].
Four studies in this virtual issue [30,32,37,38] go one step further,
by evaluating their methods with resampling schemes and
simulated datasets. Such strategies provide more insight into the
generalizability of the methods and their behavior under different
conditions, such as smaller sample sizes and varying outcome distri-
butions. With simulated datasets, one can even assess the appropri-
ateness and accuracy of a method in relation to the known truth,
which cannot be achieved with real datasets [28]. Toma et al. [32]
apply a resampling scheme (the .632 bootstrap) to their clinical
dataset to account for various sources of sample variation. They
show that their risk prediction method that utilizes frequent tempo-
ral patterns of organ failure systematically outperforms an existing
method, in terms of both mean squared error and discrimination.
Hu et al. [30] combine 10-fold cross-validation with a random
permutation scheme, and conduct a 4-way analysis of variance
(ANOVA) on the results to assess the inﬂuence of four algorithm
parameters and their interactions on predictive performance of their
method. Stajduhar and Dalbelo-Bašic´ [38] and Choi and colleagues
[37] use simulated data that are based on random number genera-
tion to investigate the properties of their methods.
Discussion
As a research ﬁeld, clinical prediction can be seen as composed of
four distinct but inter-related themes: (i) Fundamental prognosis
research, i.e. studying the nature of and variation in health related
outcomes in different geographical regions to assess the quality of
care [5]; (ii) prognostic factor research, i.e. the identiﬁcation of fac-
tors (such as biomarkers) that are associated with prognosis [6];
(iii) prognostic model research, i.e. the development, validation,
and assessment of impact of models that predict health related out-
comes for individuals [7]; and (iv) stratiﬁed medicine research: the
use of prognostic information to help tailor treatment decisions to
an individual or group of individuals with similar characteristics
[8]. The papers that are included in this virtual issue all address
prognostic model research, conﬁrming the methodological scope of
JBI. It is nevertheless remarkable that prognostic factor research is
absent. We believe that methodological research in biomedical infor-
matics can contribute to prognostic factor research, especially in the
areas of (a) reasoning about a hypothesized causal pathway from
disease to outcome and (b) hypothesis-free research to discover pre-
viously unsuspected factors. The implication is that there probably
exist unexplored opportunities in this area.
In terms of methodology, Bayesian Networks (four papers) and
logistic and CPH regression (four papers) were the most popular
ones in the collection of included papers. Of note, there was only
one (application-based) paper pertaining to ANNs and none pertain-
ing to Support Vector Machines (SVMs). Interestingly, in the same
reviewed period there were at least six papers on clinical prognostic
models pertaining to ANNs and SVMs in the Artiﬁcial Intelligence in
Medicine journal. Most of these papers focus on applications, some-
times accompanied by comparison to other approaches. It is likely
that JBI’s publication acceptance policy is geared more than AIIM’s
towards the methodological contributions itself rather than the
use, per se, of such relatively new approaches. In comparison to JBI
and AIIM, the journal Methods of Information in Medicine had the
least papers on prognostic methods (less than ﬁve in the reviewed
period), with a focus on more traditional statistical approaches.
To conclude, the development and evaluation of clinical prognos-
tic methods is a vivid area of methodological research, with frequent
4 Clinical prognostic methods: Trends and developments / Journal of Biomedical Informatics 48 (2014) 1–4contributions in JBI. Most of the published papers in the journal
build on, and extend, established data-driven prediction methods.
They typically focus on the interplay between clinical application
and methods from statistical modeling and machine learning,
exploring the opportunities to improve reliable prediction of patient
outcomes.
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